Ponatinib (AP24534)

Catalog No.S1490

Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.

Price Stock Quantity  
USD 100 In stock
USD 110 In stock
USD 370 In stock
USD 970 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Ponatinib (AP24534) Chemical Structure

Ponatinib (AP24534) Chemical Structure
Molecular Weight: 532.56

Validation & Quality Control

2 customer reviews :

Quality Control & MSDS

Related Compound Libraries

Bcr-Abl Inhibitors with Unique Features

  • Selective Bcr-Abl Inhibitor

    Nilotinib (AMN-107) Bcr-Abl-selective, IC50<30 nM.

  • Most Potent Bcr-Abl Inhibitor

    GZD824 Bcr-Abl(WT), IC50=0.34 nM; Bcr-Abl(T315I), IC50=0.68 nM.

  • FDA-approved Bcr-Abl Inhibitor

    Dasatinib Approved by FDA for CML and Ph+ ALL.

  • Newest Bcr-Abl Inhibitor

    GZD824 Orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Product Information

  • Compare Bcr-Abl Inhibitors
    Compare Bcr-Abl Products
  • Research Area
  • Ponatinib (AP24534) Mechanism

Product Description

Biological Activity

Description Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM in cell-free assays, respectively.
Targets Abl [1]
(Cell-free assay)
PDGFRα [1]
(Cell-free assay)
VEGFR2 [1]
(Cell-free assay)
FGFR1 [1]
(Cell-free assay)

 View  More

IC50 0.37 nM 1.1 nM 1.5 nM 2.2 nM
In vitro AP24534 potently inhibits native Abl, AblT315I, and other clinically important Abl kinase domain mutants with IC50 of 0.30 nM–2 nM. AP24534 doesn't inhibit Aurora kinase family members, nor does it inhibit insulin receptor or CDK2/cyclin E. AP24534 inhibits proliferation of Ba/F3 cells expressing Bcr-Abl with IC50 of 0.5 nM, as well as Ba/F3 cells expressing a range of Bcr-Abl mutants with IC50 of 0.5 nM–36 nM. The inhibition of proliferation by AP24534 is correlated with induction of apoptosis. [1-2] In leukemic cell lines containing activated forms of FLT3, KIT, FGFR1, and PDGFRα receptors, AP24534 potently inhibits receptor phosphorylation and cellular proliferation with IC50 of 0.3 nM to 20 nM. In MV4-11 (FLT3-ITD(+/+)) but not RS4;11 (FLT3-ITD(–/–)) AML cells, AP24534 inhibits FLT3 signaling and induced apoptosis at less than 10 nM. AP24534 inhibits viability of primary leukemic blasts from a FLT3-ITD positive AML patient with IC50 of 4 nM but not those from patients with AML expressing native FLT3. [3] In Ba/F3 cells engineered to express activated FGFR1-4, AP24534 potently inhibits FGFR-mediated signaling and viability with IC50 lower than 40 nM. In cell lines representing multiple tumor types (endometrial, bladder, gastric, breast, lung, and colon), and containing FGFRs dysregulated by a variety of mechanisms, AP24534 inhibits FGFR-mediated signaling with IC50 less than 40 nM and inhibits cell growth with IC50 of 7 nM–181 nM. [4]
Cell Data
Cell LinesAssay TypeConcentrationIncubation TimeFormulationActivity DescriptionPMID
EoL-1-cellMXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXPlVFltUUN3ME2wMlAxODByMECzOVkh|ryPMm\EV2FPT0WU
MV-4-11NG\PdndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofBTWM2OD1yLkCwNFA6PTZizszNMl\0V2FPT0WU
MEG-01NV\Qb2dOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHzlXoJKSzVyPUCuNFAxOTJ6IN88US=>NVnoWnpUW0GQR1XS
LAMA-84M2HXNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml7LTWM2OD1yLkCwNFE3PSEQvF2=MXLTRW5ITVJ?
CGTH-W-1M3W3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVr5OJdWUUN3ME2wMlAxOTZ7IN88US=>MUjTRW5ITVJ?
KASUMI-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4LqfmlEPTB;MD6wNFIyPyEQvF2=NXLnNZZCW0GQR1XS
BE-13MmT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEnpTZNKSzVyPUCuNFAzPTlizszNNEWxemhUSU6JRWK=
CTV-1M4D2VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MYfJR|UxRTBwMEC1NlEh|ryPMlzjV2FPT0WU
NKM-1M2fSOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEW3cFBKSzVyPUCuNFA3PTVizszNMXXTRW5ITVJ?
MONO-MAC-6NGOyOIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX;JR|UxRTBwMEC4N|ch|ryPMYTTRW5ITVJ?
A204MkTOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml3zTWM2OD1yLkCxNlE5KM7:TR?=MWTTRW5ITVJ?
GDM-1MkTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{G4SGlEPTB;MD6wNVg{OyEQvF2=NUG0dpV6W0GQR1XS
AN3-CANGXOdHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRTBwMEG4O|Mh|ryPM{jWcnNCVkeHUh?=
BL-70MnPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHvQNXVKSzVyPUCuNFIyQTlizszNNFznPIFUSU6JRWK=
DaudiNGnvZ|dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXXJR|UxRTBwMEK1N|ch|ryPMVzTRW5ITVJ?
KU812NYPh[29bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEG3ZoRKSzVyPUCuNFI5PDhizszNNFfXZ4ZUSU6JRWK=
KG-1NVHtc|M4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYLJR|UxRTBwMEOyPVQh|ryPNILnd2tUSU6JRWK=
DOHH-2MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHvIblVKSzVyPUCuNFQ5ODNizszNMUPTRW5ITVJ?
HuO9NFPGXlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHjU[FhKSzVyPUCuNFU1PDhizszNMmSzV2FPT0WU
EB2Ml76S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{PINmlEPTB;MD6wOVU4PiEQvF2=Ml73V2FPT0WU
G-402NXjVUGtLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrFb|VKSzVyPUCuNFY{PDFizszNMX7TRW5ITVJ?
SU-DHL-1NF;3NGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVv5UFlRUUN3ME2wMlA3Ozd7IN88US=>M{foW3NCVkeHUh?=
NCI-H719MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWnJR|UxRTBwMEe4PFgh|ryPM{XMUnNCVkeHUh?=
MLMAMUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnX6TWM2OD1yLkC5NFYh|ryPMnHMV2FPT0WU
KM12NFfGcopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXnibow3UUN3ME2wMlA6PzN5IN88US=>NF70OGZUSU6JRWK=
SUP-T1M4qwOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTDU4hKSzVyPUCuNFk6QDJizszNNF7Fc2VUSU6JRWK=
MZ1-PCMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVu5d2t3UUN3ME2wMlEyOzN4IN88US=>NHXYS5JUSU6JRWK=
MFE-296NXnLTVZZT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4DDcmlEPTB;MD6xNVg{QSEQvF2=MoDtV2FPT0WU
ALL-PONFXiflZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MljNTWM2OD1yLkGyOFQ{KM7:TR?=NXf4fXVDW0GQR1XS
GB-1NGnzOZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLCZldzUUN3ME2wMlEzPTF{IN88US=>NYfs[2E{W0GQR1XS
SIG-M5NGDiW|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV\JR|UxRTBwMUOzO{DPxE1?MknLV2FPT0WU
P30-OHKMW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYPJR|UxRTBwMUW2O|Ih|ryPM3:3dXNCVkeHUh?=
NCI-H716MomzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NI\ld2dKSzVyPUCuNVYzPjZizszNMV\TRW5ITVJ?
MPP-89MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1vjemlEPTB;MD6xOlk{OyEQvF2=NEiwdYpUSU6JRWK=
SF126NV\uOVA3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGDCUZJKSzVyPUCuNVcxPjNizszNMke3V2FPT0WU
CTB-1NXHYd2I5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH60TFJKSzVyPUCuNVc{OTZizszNMV3TRW5ITVJ?
CA46NHntOmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXTJR|UxRTBwMUe0PFkh|ryPNH7rSYVUSU6JRWK=
NCI-H520Moe4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVnJR|UxRTBwMUe3N|Ih|ryPMYLTRW5ITVJ?
CAL-85-1Mmm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYrhdG12UUN3ME2wMlE4QTJ5IN88US=>MmH2V2FPT0WU
NCI-H2342NWO2W4c3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTBwMUi1O|ch|ryPM2HnWHNCVkeHUh?=
697M3vLTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYDJNW5JUUN3ME2wMlE5QDdzIN88US=>M1LyXnNCVkeHUh?=
NYNHzHRnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFnHb5lKSzVyPUCuNVkzQDdizszNNWXob|dCW0GQR1XS
T98GM1XCUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUfJR|UxRTBwMUmzNVgh|ryPMUjTRW5ITVJ?
NCI-H1703M{Dqcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\LeFlrUUN3ME2wMlE6PjF3IN88US=>MXfTRW5ITVJ?
NCI-H2087MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NUHwNopRUUN3ME2wMlIxPDN7IN88US=>M{DyTHNCVkeHUh?=
PF-382MmnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoT5TWM2OD1yLkKwPFc{KM7:TR?=MmPEV2FPT0WU
HCT-116MkTJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7TTFNKUUN3ME2wMlIyODZ7IN88US=>MYPTRW5ITVJ?
CAKI-1Ml7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlHKTWM2OD1yLkKxOlY3KM7:TR?=MmW4V2FPT0WU
CCF-STTG1MnflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Ml7hTWM2OD1yLkKyOFc2KM7:TR?=M{LMTHNCVkeHUh?=
D-392MGNYrlWlB6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{DUcmlEPTB;MD6yN|E4PyEQvF2=NYXReJpEW0GQR1XS
RT-112MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUHJR|UxRTBwMkO3PVUh|ryPM3PJW3NCVkeHUh?=
MES-SAMo[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MmPOTWM2OD1yLkK0NVg4KM7:TR?=Mn\UV2FPT0WU
LC-2-adNH7XSXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlGwTWM2OD1yLkK0NlY2KM7:TR?=M1;3XnNCVkeHUh?=
NOS-1MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3HiNmlEPTB;MD6yOFM3PyEQvF2=NVPBcYh1W0GQR1XS
NALM-6M4TOPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX7kZpBFUUN3ME2wMlI2PTR|IN88US=>MnvDV2FPT0WU
TE-15M{fpT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3rNeGlEPTB;MD6yOlA6OSEQvF2=MWnTRW5ITVJ?
786-0MnTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHfHR|JKSzVyPUCuNlYzOjhizszNMnjYV2FPT0WU
IST-MES1M2LGeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYDCc4JEUUN3ME2wMlI3QDJ7IN88US=>M2LBOXNCVkeHUh?=
KYSE-180NWf3R5FJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUDJR|UxRTBwMk[4PVEh|ryPNV70[mVVW0GQR1XS
YTMlXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFr3WoZKSzVyPUCuNlY6PzRizszNMUPTRW5ITVJ?
A427MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mlv1TWM2OD1yLkK3NlY1KM7:TR?=MUfTRW5ITVJ?
KYSE-450MlrhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX\JR|UxRTBwMkezNlkh|ryPMljoV2FPT0WU
HuH-7Mn;zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDBW5BYUUN3ME2wMlI4PzZ|IN88US=>NIDIN|dUSU6JRWK=
CAS-1Mo\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTBwMkizNFMh|ryPMl;HV2FPT0WU
KURAMOCHIM4\mWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlPNTWM2OD1yLkK4OFE6KM7:TR?=NXixXJBuW0GQR1XS
ACHNNW[yb2pJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4j4eGlEPTB;MD6yPVMzOyEQvF2=M4\WPHNCVkeHUh?=
HGC-27MmnaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGTuXolKSzVyPUCuNlk{PTNizszNMke2V2FPT0WU
A172M1K4V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPPcYFJUUN3ME2wMlI6PTd5IN88US=>MXnTRW5ITVJ?
SNU-449NGK0R3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDxTWM2OD1yLkK5PVY1KM7:TR?=M3z6N3NCVkeHUh?=
SW982NXSxbWh5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVrSNXh4UUN3ME2wMlI6QTd6IN88US=>NV3NXnVMW0GQR1XS
EFO-21MlTqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mn;wTWM2OD1yLkOwOFEyKM7:TR?=NEHsOYdUSU6JRWK=
NCI-H2030NVH1VoRmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmDKTWM2OD1yLkOxNVY1KM7:TR?=M3\qPHNCVkeHUh?=
HT-144MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2XmNmlEPTB;MD6zNVI5KM7:TR?=NYTURpRrW0GQR1XS
MFE-280MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTBwM{G0OVMh|ryPM{ThOnNCVkeHUh?=
SK-LU-1NFLyTJFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mny5TWM2OD1yLkOxOFY3KM7:TR?=M4PCb3NCVkeHUh?=
NCI-H2052NGXObZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFL3dHFKSzVyPUCuN|E1QDRizszNM4TuWHNCVkeHUh?=
SK-HEP-1M3nZeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{jXW2lEPTB;MD6zN|M3QCEQvF2=NGC2e3FUSU6JRWK=
QIMR-WILNIjBTmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M33wTWlEPTB;MD6zN|QzPCEQvF2=MXjTRW5ITVJ?
A2780NGK3VlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWDiVmc1UUN3ME2wMlM1OzB2IN88US=>Moq4V2FPT0WU
ACNMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHN[lFKSzVyPUCuN|Q5PzNizszNMVPTRW5ITVJ?
BxPC-3NWL4fYE1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXT6b3dvUUN3ME2wMlM1QTh7IN88US=>MkfoV2FPT0WU
BCPAPNWLLVHozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3u2N2lEPTB;MD6zOlAxOSEQvF2=MVzTRW5ITVJ?
HOP-62Ml3LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfFTWM2OD1yLkO2NVA3KM7:TR?=MVHTRW5ITVJ?
SW1710MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;WRWxKSzVyPUCuN|Y1PTVizszNNHfrbIZUSU6JRWK=
OPM-2MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4XCS2lEPTB;MD6zOlQ4OyEQvF2=NX7wZ5lLW0GQR1XS
DBTRG-05MGNIjIb|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUi3NpZtUUN3ME2wMlM5ODV2IN88US=>M2XjVHNCVkeHUh?=
SK-MEL-24NIO4bGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnfITWM2OD1yLkO5O|kyKM7:TR?=NH\kR|NUSU6JRWK=
8305CMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mm\uTWM2OD1yLkO5O|k{KM7:TR?=NI\BRY5USU6JRWK=
OVCAR-4NETzd5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NX74[WU5UUN3ME2wMlQyPTh4IN88US=>M2roeHNCVkeHUh?=
HLEMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4SwSmlEPTB;MD60NVg3KM7:TR?=MnXVV2FPT0WU
NCI-H747M1;iSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Ml3wTWM2OD1yLkSyNVM4KM7:TR?=NHjITZpUSU6JRWK=
SW780MkPvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTBwNEKzOFYh|ryPNEXmXVZUSU6JRWK=
KYSE-150M1Prcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXXJR|UxRTBwNEK0NVUh|ryPMmKyV2FPT0WU
H4NVTOflc6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTBwNEK0OVEh|ryPM3S0OXNCVkeHUh?=
SW1088NEXPNYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWnJR|UxRTBwNESzPUDPxE1?MonGV2FPT0WU
SF268NX3hXopsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUXVNINiUUN3ME2wMlQ1QDZizszNMoT3V2FPT0WU
RT4NGjjTmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPLTWM2OD1yLkS1NVEyKM7:TR?=Ml;oV2FPT0WU
NCI-H522M4rIS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTBwNEWyO{DPxE1?MlKxV2FPT0WU
LCLC-97TM1NITtbGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXzxdJJxUUN3ME2wMlQ3OTl3IN88US=>NH7HW2lUSU6JRWK=
CAL-39M1qwXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlziTWM2OD1yLkS2OVE6KM7:TR?=NGDnWpZUSU6JRWK=
CAL-120MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWfJR|UxRTBwNEe2OFMh|ryPM3iwdnNCVkeHUh?=
ESS-1NIXRcWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEfMWmZKSzVyPUCuOFc5OjFizszNMX3TRW5ITVJ?
KARPAS-45NF\DVJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVfJR|UxRTBwNEi5N|Mh|ryPMonYV2FPT0WU
DU-4475MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVTqOYNGUUN3ME2wMlQ6PTFzIN88US=>M4HZ[HNCVkeHUh?=
VMRC-RCZMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYXSeoF4UUN3ME2wMlQ6QTB2IN88US=>MUDTRW5ITVJ?
HOSNI\yemRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlHpTWM2OD1yLkWwN|Y2KM7:TR?=NHLGT|ZUSU6JRWK=
MOLT-16M1T0fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUP2RmJHUUN3ME2wMlUyQDB6IN88US=>MXzTRW5ITVJ?
RPMI-6666NYTCZodpT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NH7jN4dKSzVyPUCuOVIyOzVizszNNVjLNXdKW0GQR1XS
K052NYf5VJp4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{LOe2lEPTB;MD61NlE1KM7:TR?=M4qwNnNCVkeHUh?=
EHEBNYXPXJZLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVnST4xvUUN3ME2wMlUzOTh{IN88US=>MkjKV2FPT0WU
MFH-inoMnjqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUDNeG52UUN3ME2wMlUzOzVzIN88US=>M{eyUHNCVkeHUh?=
A4-FukMULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYjnRYxwUUN3ME2wMlUzPTJ6IN88US=>NXfOeotGW0GQR1XS
SW1417MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXtV3dSUUN3ME2wMlUzPzhzIN88US=>MkThV2FPT0WU
DoTc2-4510MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1fIXGlEPTB;MD61OFk2QCEQvF2=MX;TRW5ITVJ?
TE-12M{Hidmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVjJR|UxRTBwNUW3N|Uh|ryPMYPTRW5ITVJ?
8-MG-BAM{HRWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4ToR2lEPTB;MD61OlA2PiEQvF2=M2P3XnNCVkeHUh?=
ECC12MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{G5UWlEPTB;MD61OlU2QCEQvF2=NUPDR4VYW0GQR1XS
CHL-1NYrzW3E4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGn6ZXRKSzVyPUCuOVc1PjNizszNM3jPTXNCVkeHUh?=
LCLC-103HNGfXPJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MnjKTWM2OD1yLkW4N|Q1KM7:TR?=MYXTRW5ITVJ?
OS-RC-2MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXXtVXgyUUN3ME2wMlU5Ozd7IN88US=>NVO4[FBQW0GQR1XS
RO82-W-1MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13FV2lEPTB;MD61PVYyPSEQvF2=MU\TRW5ITVJ?
A3-KAWM3T1dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{\KPGlEPTB;MD62NVQ3PyEQvF2=NVr6VlcyW0GQR1XS
NCCITMVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;2XWlEPTB;MD62NVcyPSEQvF2=NXXHRYRiW0GQR1XS
IST-SL2M{DFWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV:0dllLUUN3ME2wMlYzPTJ{IN88US=>M1;ubXNCVkeHUh?=
GI-ME-NMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\VemM2UUN3ME2wMlY{ODZ7IN88US=>MYfTRW5ITVJ?
ES6NVj1[|hIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NI\6[|JKSzVyPUCuOlMzQTVizszNNWDqOZFuW0GQR1XS
BL-41NEDjNIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTBwNkOzOVIh|ryPMUHTRW5ITVJ?
Ca-SkiMWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M321NGlEPTB;MD62OFgyKM7:TR?=NWDXco5EW0GQR1XS
HOP-92MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTBwNkW2O|Ih|ryPMoPmV2FPT0WU
SK-LMS-1MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnXiTWM2OD1yLk[2OFch|ryPNGO4eZNUSU6JRWK=
EW-13Ml7aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVjtNWxJUUN3ME2wMlY3Pzd7IN88US=>NEHZR5dUSU6JRWK=
647-VM3jsV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnnQTWM2OD1yLk[4NVQ5KM7:TR?=M3HYTnNCVkeHUh?=
JiyoyeP-2003M3HJfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NE\nXWVKSzVyPUCuOlk4OzhizszNMlH4V2FPT0WU
WSU-NHLM4r3PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NX:yN4hOUUN3ME2wMlcxQDh5IN88US=>NYDFeI81W0GQR1XS
U-698-MMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mk\vTWM2OD1yLkexNFY{KM7:TR?=NYO2UGVlW0GQR1XS
HC-1MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NE[4bZRKSzVyPUCuO|I1ODVizszNMmixV2FPT0WU
8505CM4LCRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoTETWM2OD1yLkeyO|QyKM7:TR?=M3Owc3NCVkeHUh?=
HUTU-80MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVvYcWRRUUN3ME2wMlc{OzR7IN88US=>MX7TRW5ITVJ?
LB1047-RCCMV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnqVGFKSzVyPUCuO|M2OzhizszNNFrKUphUSU6JRWK=
GAMGNVn4b3I6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVnJR|UxRTBwN{O2OVMh|ryPMYHTRW5ITVJ?
CAL-12TMnfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYnN[5pRUUN3ME2wMlc{QDd5IN88US=>MkDIV2FPT0WU
NCI-SNU-1MoHhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NE\1So9KSzVyPUCuO|czPzhizszNNUjCeFRjW0GQR1XS
HTC-C3NF;BW3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTBwN{e0OVEh|ryPNI[3cJJUSU6JRWK=
HPAF-IIMUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1HGNmlEPTB;MD63O|UxOSEQvF2=M1T3eXNCVkeHUh?=
KGNMnvES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NX7hb|FSUUN3ME2wMlc5ODhzIN88US=>M4fQ[nNCVkeHUh?=
EFO-27M3HF[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDx[GNYUUN3ME2wMlc5PzN|IN88US=>NXr1NWxmW0GQR1XS
MEL-HOMoPxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWLJR|UxRTBwN{m0OFkh|ryPMWTTRW5ITVJ?
KYSE-270M2ny[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXXT|FKSzVyPUCuPFA2OjlizszNNH3MT3JUSU6JRWK=
NCI-H1755MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTBwOEC3NVQh|ryPM1HOTnNCVkeHUh?=
MFM-223MnS1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGDHWlhKSzVyPUCuPFE1ODdizszNMnPXV2FPT0WU
G-361MnfYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1XhXGlEPTB;MD64NVg6PyEQvF2=NImyWoVUSU6JRWK=
ETK-1MnXCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFq3bXdKSzVyPUCuPFI1PDFizszNNGPVS4VUSU6JRWK=
LU-99ANGLQdZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1vnU2lEPTB;MD64OFcxOSEQvF2=Mn7DV2FPT0WU
IST-MEL1M4TlU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\SW5VKSzVyPUCuPFU4OzJizszNNH3ZOHpUSU6JRWK=
L-540NXfDZYd1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MoXPTWM2OD1yLki1PFAyKM7:TR?=M1jLZXNCVkeHUh?=
U-2-OSMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHrET5hKSzVyPUCuPFU5PDZizszNMYLTRW5ITVJ?
HT-1376M1jDTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXBTWM2OD1yLki2NFUyKM7:TR?=MmD3V2FPT0WU
COLO-680NMXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NYOxbINMUUN3ME2wMlg4QTN|IN88US=>MXPTRW5ITVJ?
NCI-H1581MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXfJR|UxRTBwOEmyPVch|ryPM3;KNXNCVkeHUh?=
HuCCT1NWHvSGNkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVfJR|UxRTBwOEm1OFgh|ryPMVzTRW5ITVJ?
BB30-HNCNEfkPJhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4nSXWlEPTB;MD65NlQ3QSEQvF2=M2nHUHNCVkeHUh?=
NCI-H2347MnnoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{LaZWlEPTB;MD65N|I6OiEQvF2=MoLsV2FPT0WU
G-401NWDv[4ROT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXHJR|UxRTBwOUO2PVUh|ryPM2XQ[XNCVkeHUh?=
NCI-H358MlLmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV7HelV[UUN3ME2wMlk2ODF2IN88US=>NH\2ZVRUSU6JRWK=
HCC1395M1zGWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NH\RPFRKSzVyPUCuPVU1PjFizszNNXLiW|ZSW0GQR1XS
J82NID5Oo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkHRTWM2OD1yLkm1OVQ{KM7:TR?=NGnHdI1USU6JRWK=
KE-37M2HacWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NImxfphKSzVyPUCuPVY{QDdizszNNELIb3lUSU6JRWK=
NOMO-1NWDSUYV2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX;L[Y1PUUN3ME2wMlk3PTZ2IN88US=>NHzzVXdUSU6JRWK=
ML-2MnrzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHz3RnRKSzVyPUCuPVk4PSEQvF2=M{P3SnNCVkeHUh?=
SW872Mk\SS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M17h[WlEPTB;MD65PVc4PSEQvF2=NY\RcZZWW0GQR1XS
KYSE-520M3W2PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlvJTWM2OD1zLkCwOFk1KM7:TR?=M2DNOHNCVkeHUh?=
HL-60M1jL[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUPiUYlTUUN3ME2xMlAxQTdizszNNHHGZ5VUSU6JRWK=
HDLM-2M2PR[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHXneYVKSzVyPUGuNFEzPTJizszNNEjPc4lUSU6JRWK=
MIA-PaCa-2MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFT2UZRKSzVyPUGuNFE{PzVizszNM3rxNHNCVkeHUh?=
TCCSUPMUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1XpWWlEPTB;MT6wNVc{OiEQvF2=MWnTRW5ITVJ?
SH-4M3jLemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGLMUXNKSzVyPUGuNFIzPDRizszNNV7QZVhrW0GQR1XS
MG-63MonuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkXMTWM2OD1zLkCyOlE3KM7:TR?=NVvyNWlHW0GQR1XS
NB6M2LxZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXLoOVVLUUN3ME2xMlA{OTB7IN88US=>NIHGWYVUSU6JRWK=
CAL-54MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHqyXmhKSzVyPUGuNFM6PTlizszNM335bnNCVkeHUh?=
DU-145NIX3eFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MV3JR|UxRTFwMEiwO|Mh|ryPMnn5V2FPT0WU
HCE-4NH62PIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYrJR|UxRTFwMEmyPFYh|ryPNWTyVVlnW0GQR1XS
U-266M4PneGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkL5TWM2OD1zLkC5OlM{KM7:TR?=MV\TRW5ITVJ?
HT-1197MnXUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTFwMUG0N|gh|ryPMmezV2FPT0WU
EW-1NWS3PZFOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXrpdJczUUN3ME2xMlE1OTJ6IN88US=>NVjDdYlkW0GQR1XS
MHH-NB-11MlX4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MW\JR|UxRTFwMUWzOlgh|ryPNXPySFZnW0GQR1XS
NCI-H2405MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1\vcGlEPTB;MT6xOlE3KM7:TR?=M1fKc3NCVkeHUh?=
COLO-668MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2CxbGlEPTB;MT6xOlQ6KM7:TR?=NFPnbWVUSU6JRWK=
IMR-5MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M13s[WlEPTB;MT6xOlk{PiEQvF2=NF65PZZUSU6JRWK=
ARH-77M1W0dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLCdopWUUN3ME2xMlIzQTJ2IN88US=>NH3v[3FUSU6JRWK=
BHT-101NIrHS4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjy[|dKSzVyPUGuNlM1QSEQvF2=MofOV2FPT0WU
SCC-25NI\BV5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MoLsTWM2OD1zLkKzOVM3KM7:TR?=M1rD[XNCVkeHUh?=
NTERA-S-cl-D1MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnPITWM2OD1zLkK0N|Q3KM7:TR?=NU\2NpB3W0GQR1XS
MKN28NWCzZodmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTFwMkW2N|Yh|ryPMYLTRW5ITVJ?
KS-1MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVXJR|UxRTFwMkiyOlkh|ryPNGfS[ndUSU6JRWK=
NCI-H1734MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnP0TWM2OD1zLkK4PVE{KM7:TR?=M32yXXNCVkeHUh?=
ES7NV[3RZZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NY\RUlhRUUN3ME2xMlI6PTR{IN88US=>M17uTHNCVkeHUh?=
NCI-H838NXPuSnVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmHtTWM2OD1zLkOwOlE2KM7:TR?=MXPTRW5ITVJ?
HEC-1MnTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1v3W2lEPTB;MT6zN|c2PSEQvF2=M{L5c3NCVkeHUh?=
ME-180NUHHTYIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1LCVGlEPTB;MT6zO|k6OyEQvF2=NH;4TY1USU6JRWK=
MMAC-SFMn;RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3W5c2lEPTB;MT6zPVU6PSEQvF2=NYe0Wnc{W0GQR1XS
IA-LMNYXVeol2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXfJR|UxRTFwNEC5NVQh|ryPNIXENVVUSU6JRWK=
MN-60MnvCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1n1dWlEPTB;MT60N|EyPCEQvF2=MWnTRW5ITVJ?
SIMAMoPLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3yy[2lEPTB;MT60PFY5PyEQvF2=MWHTRW5ITVJ?
NCI-H1770MmnMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoW5TWM2OD1zLkWyNFU1KM7:TR?=NYrnPWpXW0GQR1XS
ONS-76MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M37QNGlEPTB;MT61NlMyOSEQvF2=NXfa[ZF3W0GQR1XS
LB771-HNCNITR[3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUTpdoZpUUN3ME2xMlU{QTB4IN88US=>NX\zSWFxW0GQR1XS
SW48MnLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIqyNI9KSzVyPUGuOVQzPDNizszNNHPMWFJUSU6JRWK=
KYSE-140NHjCdodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUjJR|UxRTFwNUW3OFEh|ryPNUTTcm5ZW0GQR1XS
SW626MmLSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MoryTWM2OD1zLkW4NVYh|ryPM1\UN3NCVkeHUh?=
MC-CARM1PQWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfCbpRMUUN3ME2xMlU5PjZ|IN88US=>MnPoV2FPT0WU
D-336MGMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH;IPXhKSzVyPUGuOlI6PCEQvF2=MnPHV2FPT0WU
SK-MEL-3MoPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVzYU3pzUUN3ME2xMlY{QTB{IN88US=>NWHqXJpHW0GQR1XS
MHH-PREB-1MmHiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NXXWfZgxUUN3ME2xMlY1PDd|IN88US=>M4rZNXNCVkeHUh?=
Calu-1NVvwNng{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3H5NmlEPTB;MT62OVM5PiEQvF2=NEThOndUSU6JRWK=
HCC1806NHK2[GZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYTJR|UxRTFwNk[2NVEh|ryPMn7sV2FPT0WU
A101DMYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXiSXVrUUN3ME2xMlY3PzhzIN88US=>MmL2V2FPT0WU
A704NIrEV2JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2TB[GlEPTB;MT62PFMyOSEQvF2=MUnTRW5ITVJ?
LB831-BLCNYPrRm1HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHPV3diUUN3ME2xMlY6QDV2IN88US=>MVXTRW5ITVJ?
RL95-2MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnW1TWM2OD1zLkexOFY{KM7:TR?=MUfTRW5ITVJ?
RPMI-2650NGDPd5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{mybmlEPTB;MT63NlcyQSEQvF2=NVe3c|lHW0GQR1XS
NH-12MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4PLeGlEPTB;MT63N|QzPyEQvF2=Mo\CV2FPT0WU
AGSM174SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXjJR|UxRTFwN{[zOVgh|ryPMlPUV2FPT0WU
NEC8NEnJVYtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1zTbmlEPTB;MT63PFk6PSEQvF2=NX7LTJc2W0GQR1XS
NCI-H2009MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3nSO2lEPTB;MT63PVczOSEQvF2=MXTTRW5ITVJ?
A498MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlfMTWM2OD1zLkixNlgzKM7:TR?=NITXWphUSU6JRWK=
NCI-H810M1nFRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NG\zcWdKSzVyPUGuPFE3ODZizszNMlrQV2FPT0WU
SK-NEP-1NV;qSHNXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIf1dnNKSzVyPUGuPFM4PjdizszNMVHTRW5ITVJ?
D-542MGNX\pUmF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmCzTWM2OD1zLki1PFUyKM7:TR?=NF3RdZlUSU6JRWK=
KNS-42NVTTWXpMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{jTfGlEPTB;MT64OlI3PiEQvF2=MVPTRW5ITVJ?
NCI-H2452M3\FUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MY\JR|UxRTFwOEmwO|Qh|ryPNWTxU5pmW0GQR1XS
SK-MEL-2NWLnNHlbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1Pl[WlEPTB;MT65NFI4OSEQvF2=M{DQdXNCVkeHUh?=
OVCAR-5MmnFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M373O2lEPTB;MT65NFY4PSEQvF2=MlvMV2FPT0WU
SNG-MM361O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUmwdWMzUUN3ME2xMlk2QDV6IN88US=>MmjIV2FPT0WU
A673M3zPNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUTJR|UxRTFwOUe1NVYh|ryPNGTESoRUSU6JRWK=
L-428MnjXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU\UeItSUUN3ME2xMlk6OTd7IN88US=>MWjTRW5ITVJ?
KM-H2NXfSUHRbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUDv[5VzUUN3ME2yMlAyODlizszNMYLTRW5ITVJ?
MC-IXCM4D4Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYD3N5JtUUN3ME2yMlAzOjd|IN88US=>NGPNfodUSU6JRWK=
COLO-678NYm0fGFDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkP0TWM2OD1{LkC0NlA4KM7:TR?=M134UXNCVkeHUh?=
MEL-JUSOMX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoXTTWM2OD1{LkC3PFUyKM7:TR?=MYHTRW5ITVJ?
HCC38MmfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHHNUG5KSzVyPUKuNFg1OzNizszNMk\sV2FPT0WU
UACC-62M4[yVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTJwMEi4OVUh|ryPMl\qV2FPT0WU
OAW-42NGPFcppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3v3PWlEPTB;Mj6wPVcyOSEQvF2=MWnTRW5ITVJ?
LB996-RCCMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWDJR|UxRTJwMUO4NVch|ryPMmj1V2FPT0WU
COR-L105Mne5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWficm11UUN3ME2yMlE3Ozd|IN88US=>NIewfJJUSU6JRWK=
RCC10RGBNFTtXm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVj4fI1kUUN3ME2yMlE5PTd4IN88US=>MnjEV2FPT0WU
A431M1TEb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEjNTYtKSzVyPUKuNVkxOTlizszNM4HKdXNCVkeHUh?=
NCI-H292NGPu[I5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmG5TWM2OD1{LkKzPVUyKM7:TR?=M3fLWXNCVkeHUh?=
SK-UT-1Mni2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWHJR|UxRTJwM{OxPFQh|ryPMUHTRW5ITVJ?
PANC-08-13MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXwfXVOUUN3ME2yMlM{OjN3IN88US=>NH;OcVZUSU6JRWK=
ST486M17sNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NVLjW3JqUUN3ME2yMlQyODR6IN88US=>MlflV2FPT0WU
SJSA-1MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4rxbGlEPTB;Mj60NVI4OSEQvF2=M{nMXHNCVkeHUh?=
RKONYryUGlmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGPSS2tKSzVyPUKuOFIxOjlizszNM1HWdnNCVkeHUh?=
NCI-H1793NWe5fW05T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXHuPZJsUUN3ME2yMlQ1ODJ7IN88US=>M4XFbnNCVkeHUh?=
639-VMXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVe1WWs5UUN3ME2yMlQ2Ozh{IN88US=>NXL3SGUyW0GQR1XS
ES3M1nkVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTJwNEm3N|ch|ryPMVzTRW5ITVJ?
NCI-H1792MnfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVPQfnNOUUN3ME2yMlU3QDJ4IN88US=>MXrTRW5ITVJ?
NCI-H1651NYXSe4QxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkHnTWM2OD1{LkW4NlEh|ryPMnHpV2FPT0WU
SN12CMlLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1jKT2lEPTB;Mj61PFQ5PyEQvF2=NFvRTXNUSU6JRWK=
COLO-679MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVLYUGV4UUN3ME2yMlU5PjB3IN88US=>MmLoV2FPT0WU
U-118-MGNGG0XWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1fZXGlEPTB;Mj61PFg4OiEQvF2=MYHTRW5ITVJ?
Ramos-2G6-4C10NHS0OIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Mm[xTWM2OD1{Lk[0PFA4KM7:TR?=MofFV2FPT0WU
HCT-15NV;peo1bT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFSyPG5KSzVyPUKuOlg4QTJizszNMmHUV2FPT0WU
MDA-MB-157M4\OdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlLqTWM2OD1{LkewO|Q4KM7:TR?=MlPRV2FPT0WU
K5NYX1VJBET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2HQXWlEPTB;Mj63NVg1PSEQvF2=NFe5PGdUSU6JRWK=
MKN45MnTUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlPyTWM2OD1{LkezN|Y3KM7:TR?=MlHWV2FPT0WU
DMS-273NY[4fFB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXTJR|UxRTJwN{W2N|Ih|ryPMX\TRW5ITVJ?
C8166NXvJclRFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV:wUWJoUUN3ME2yMlc5PTF|IN88US=>NXHDS4ZNW0GQR1XS
Calu-3MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?Mn;XTWM2OD1{Lke4PVY6KM7:TR?=MnSwV2FPT0WU
SNB75NFLqUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{X2WmlEPTB;Mj64PFU{PSEQvF2=NXvCU3ZUW0GQR1XS
BFTC-905NYrqZYlWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHvqfodKSzVyPUKuPVAyQTFizszNNFnBSJZUSU6JRWK=
C-4-IINFnoO4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2fOZmlEPTB;Mj65NVM2OyEQvF2=MWfTRW5ITVJ?
MS-1MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmPvTWM2OD1{Lkm2O|Y6KM7:TR?=M3rmRnNCVkeHUh?=
A375MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX\JR|UxRTNwMEixPFQh|ryPMWrTRW5ITVJ?
KYSE-70MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlvGTWM2OD1|LkC4PFgzKM7:TR?=NX;i[I55W0GQR1XS
KYSE-510MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH7ye5RKSzVyPUOuNVA6QTVizszNMnPXV2FPT0WU
LN-405Mkn3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFzNb5ZKSzVyPUOuNVM2OThizszNMnnrV2FPT0WU
BOKUNIrkNolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGTIb4tKSzVyPUOuNVQzPTZizszNM1\zWXNCVkeHUh?=
TE-10NWfPc3dTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fqTWlEPTB;Mz6xO|M3OiEQvF2=NVTlUpZzW0GQR1XS
MKN1Ml\zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{[xWGlEPTB;Mz6xPFQ5OyEQvF2=NYfiXZRNW0GQR1XS
M059JNHjhW|JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXfnbXRSUUN3ME2zMlIxOTd|IN88US=>MmO1V2FPT0WU
GOTOM1rJVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYXMcFhKUUN3ME2zMlIzODN7IN88US=>NIjiOJJUSU6JRWK=
DK-MGMYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NIDBNpZKSzVyPUOuNlU6PzZizszNM3mzZXNCVkeHUh?=
NCI-H727NVjYeIpYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NGTicJFKSzVyPUOuNlY2QCEQvF2=NVX6VGx4W0GQR1XS
NB12NX3ybItiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MW\JR|UxRTNwM{OyNlQh|ryPMXnTRW5ITVJ?
DOKNH23RYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MUnJR|UxRTNwM{[xPFYh|ryPM4T6WHNCVkeHUh?=
KYSE-410NHi1UVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MY\JR|UxRTNwM{[yPFch|ryPNF;oTG1USU6JRWK=
AM-38M2jjZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXnJR|UxRTNwM{iwOVEh|ryPNYXDPZl3W0GQR1XS
GR-STM{XDb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4nHd2lEPTB;Mz60OVc{OiEQvF2=MXHTRW5ITVJ?
D-247MGNX;nVYw3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkfZTWM2OD1|LkS4NlY{KM7:TR?=MWLTRW5ITVJ?
TE-8MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MlnvTWM2OD1|LkS5N|M{KM7:TR?=Ml31V2FPT0WU
LS-411NMlKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NU[zd3VLUUN3ME2zMlQ6Pjl{IN88US=>MYjTRW5ITVJ?
SK-MES-1MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmrzTWM2OD1|LkW2OFM{KM7:TR?=Mn35V2FPT0WU
SF295MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXjJR|UxRTNwNkG1OVIh|ryPNWD4TJR1W0GQR1XS
SK-MEL-30NXz5T3JPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mn\6TWM2OD1|Lk[1PVIyKM7:TR?=NYrGZXRbW0GQR1XS
LB2241-RCCNInpN5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MX3JR|UxRTNwNk[yOkDPxE1?M3:5NnNCVkeHUh?=
PC-14MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NELWWJRKSzVyPUOuOlY1OzdizszNMnLFV2FPT0WU
EW-7M1LpZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MlXFTWM2OD1|Lk[3Olk{KM7:TR?=MUHTRW5ITVJ?
NMC-G1MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTNwN{G4N|ch|ryPM1zjUnNCVkeHUh?=
TE-441-TNEXRfnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlXBTWM2OD1|LkezNFI5KM7:TR?=NITtbFlUSU6JRWK=
NCI-H1618MkflS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRTNwOEG4O|Uh|ryPNI\RVndUSU6JRWK=
PANC-03-27MofwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NVTEWJNpUUN3ME2zMlgyQTF4IN88US=>NImzWGxUSU6JRWK=
NCI-H2228M4WzXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnL5TWM2OD1|LkizNVI3KM7:TR?=NE\zSFBUSU6JRWK=
CAPAN-1NELEVI5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGPLc2hKSzVyPUOuPFcxODlizszNM4PlNXNCVkeHUh?=
KLEMlPIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYWzZ21SUUN3ME2zMlkxPjdizszNM4CwbnNCVkeHUh?=
BeckerNWjOWpJFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1fU[2lEPTB;Mz65Nlg1QSEQvF2=NFr1OVFUSU6JRWK=
SK-PN-DWM4faUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3vzXGlEPTB;ND6wO|k4PCEQvF2=M1S5bnNCVkeHUh?=
Hs-578-TM3vRWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHntZpFKSzVyPUSuNFg{ODZizszNNHzCe|lUSU6JRWK=
RS4-11M3m5eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mo\DTWM2OD12LkGxNlU2KM7:TR?=MlLSV2FPT0WU
D-502MGNFrXSlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4LON2lEPTB;ND6xOlk6PyEQvF2=NVzWO4NtW0GQR1XS
GI-1NFXlNm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHTMZZlKSzVyPUSuNlgzQTlizszNMomzV2FPT0WU
NCI-H209MmPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWjJR|UxRTRwM{O3PEDPxE1?NF7wSZlUSU6JRWK=
SK-OV-3MkX6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUTTUXQ4UUN3ME20MlQ5OTR7IN88US=>M{LYSnNCVkeHUh?=
LOUCYM{X0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M13ZRWlEPTB;ND60PFQ{OiEQvF2=Mk\2V2FPT0WU
NCI-H69NFPrbWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYLJR|UxRTRwNUG3PVMh|ryPMWnTRW5ITVJ?
SCC-9MmDWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3nUcWlEPTB;ND61N|E4OiEQvF2=MV7TRW5ITVJ?
NCI-H526MkPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTRwNUmyPVMh|ryPMVHTRW5ITVJ?
NCI-H2170NVr5U4tmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NVzheGZrUUN3ME20MlY3PzdzIN88US=>NIjjVIJUSU6JRWK=
SRMm\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4fHVGlEPTB;ND63NFA1QCEQvF2=M164UnNCVkeHUh?=
CMKMXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVXkTlI2UUN3ME20MlczOTBzIN88US=>MWnTRW5ITVJ?
COLO-829M{PiWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkHRTWM2OD12Lke3NFQ{KM7:TR?=MYXTRW5ITVJ?
HuO-3N1MnT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MV\JR|UxRTRwOEOyPFEh|ryPMn\OV2FPT0WU
5637NVvzWoVJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M37JUmlEPTB;ND65NFQ5PyEQvF2=M3TSNXNCVkeHUh?=
A253Mn\sS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYqx[2NmUUN3ME20Mlk4PzB6IN88US=>MUDTRW5ITVJ?
NB10MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTVwMEe0PVch|ryPMV3TRW5ITVJ?
SF539M4DZZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkTMTWM2OD13LkC5PVU6KM7:TR?=MXzTRW5ITVJ?
HAL-01NW\1OIEyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M160R2lEPTB;NT6xOFY1PSEQvF2=M{LDd3NCVkeHUh?=
MHH-ES-1M3zOXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2fDWWlEPTB;NT6xOlkzPSEQvF2=NX3GUZdjW0GQR1XS
DELMm\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4e1dGlEPTB;NT6yO|U5OiEQvF2=Mkj6V2FPT0WU
NCI-H1299NI\5cZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NF;2ZlFKSzVyPUWuN|UxODdizszNMYDTRW5ITVJ?
ChaGo-K-1MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NHHCeGNKSzVyPUWuN|UyODdizszNNIrpUpdUSU6JRWK=
HMV-IIMmHTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NULiXnBZUUN3ME21MlM6PDNizszNM3f1UXNCVkeHUh?=
NB69MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MX7JR|UxRTVwM{m2N|Eh|ryPM4HmfXNCVkeHUh?=
NCI-H1882NWPyT4FiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYD5SohGUUN3ME21MlQ{OzZ2IN88US=>M1vCVnNCVkeHUh?=
SNU-475NY\4ZlNoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4f4SmlEPTB;NT60O|E4OSEQvF2=MnWyV2FPT0WU
RXF393M{PrdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NV7hUlRsUUN3ME21MlQ5PDl2IN88US=>MmXWV2FPT0WU
CAL-51M2O1cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MWnJR|UxRTVwNkK4OVMh|ryPMYPTRW5ITVJ?
SW1573M3j2dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3jsdGlEPTB;NT62N|U{PCEQvF2=MlXvV2FPT0WU
GCTMYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2HPe2lEPTB;NT63OVkzQSEQvF2=NX;sOYY6W0GQR1XS
COR-L88M{jXZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYfi[Gw6UUN3ME21Mlc3QDR4IN88US=>MXTTRW5ITVJ?
MDA-MB-134-VIMnXGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHexRm1KSzVyPUWuPFc2OzZizszNNH[0N|FUSU6JRWK=
NB5Ml;IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrwbpNKSzVyPUWuPVI1PCEQvF2=MnzBV2FPT0WU
GMS-10M{\3WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGTsbJpKSzVyPUWuPVY5PjFizszNM2HKdnNCVkeHUh?=
CHP-212MnezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{D0OmlEPTB;Nj60PFI3PyEQvF2=Mm\VV2FPT0WU
TE-11NF\qTY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MofqTWM2OD14LkW1NVgzKM7:TR?=NHTKUY9USU6JRWK=
SW962MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV\JR|UxRTZwNkW3O|Qh|ryPNFq1XXlUSU6JRWK=
MZ2-MELNHTxc2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NXLxUIhkUUN3ME22MlgzODFzIN88US=>NWLnRWdyW0GQR1XS
C-33-AMXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4DsfGlEPTB;Nj65NVY5QCEQvF2=M{e5d3NCVkeHUh?=
IGR-1M4DBWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MoPPTWM2OD14Lkm3PFI3KM7:TR?=M{T0V3NCVkeHUh?=
MOLT-4NHzVfldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MU\JR|UxRTdwMUW0NFYh|ryPM4rzWnNCVkeHUh?=
NCI-H1650M3XFXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYLndXdsUUN3ME23MlI4ODR4IN88US=>NHvhUFNUSU6JRWK=
AsPC-1NI[1eJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MVTJR|UxRTdwMki2NFUh|ryPMlHxV2FPT0WU
SNU-C2BMly3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M3G2b2lEPTB;Nz6yPVU4OSEQvF2=M{jhVXNCVkeHUh?=
MKN7MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWK5T2VUUUN3ME23MlM4OjN3IN88US=>MkjBV2FPT0WU
SW620NWPNfFB1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moe5TWM2OD15LkO4NlA2KM7:TR?=M4TEd3NCVkeHUh?=
SK-MEL-28NYq0bJFmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXjJR|UxRTdwNEC3PVgh|ryPNETkOFRUSU6JRWK=
TE-6MlezS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYnJR|UxRTdwNES5NFgh|ryPMlLCV2FPT0WU
D-263MGNGrLT4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYLxVGI4UUN3ME23MlQ2PzZ{IN88US=>MonFV2FPT0WU
NCI-H1355MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NX\lUYN1UUN3ME23Mlc4ODJ7IN88US=>MX;TRW5ITVJ?
DSH1NXvIOmN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUnJR|UxRTdwN{m3OlIh|ryPNFnkPZFUSU6JRWK=
NCI-H460MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnnnTWM2OD16LkCwOlk1KM7:TR?=MVHTRW5ITVJ?
NCI-H1563NVv0NoFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV\RdlIyUUN3ME24MlA4PTB6IN88US=>NH;C[JJUSU6JRWK=
SW948MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4S2cmlEPTB;OD6xNFc1PCEQvF2=NH;BSGRUSU6JRWK=
LK-2M4eyOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXPiSnBvUUN3ME24MlEzQDN|IN88US=>NInYXpdUSU6JRWK=
HT-1080NVLNRWIyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MUfJR|UxRThwMUOxO|Uh|ryPMXHTRW5ITVJ?
NCI-H441NILzSnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{Pk[mlEPTB;OD6xPVMh|ryPNWjrRpNwW0GQR1XS
HSC-4M4f0SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4HDWWlEPTB;OD6yPFczKM7:TR?=NWnlOWJLW0GQR1XS
LXF-289M{T2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4XuUmlEPTB;OD6zOVk1OyEQvF2=NXHaT5IzW0GQR1XS
MRK-nu-1Mo[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRThwM{[zNFQh|ryPM1;IOnNCVkeHUh?=
no-11MlPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M2T3VWlEPTB;OD60O|E{OyEQvF2=NYrS[FJqW0GQR1XS
SNU-387NYPBUYlDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIWyT4dKSzVyPUiuOlMzPDZizszNNI\hRYJUSU6JRWK=
Detroit562MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NGnTc2FKSzVyPUiuO|U1PTVizszNMnHHV2FPT0WU
SW954MlrFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX7JR|UxRThwN{[4N|Ih|ryPM331SnNCVkeHUh?=
P12-ICHIKAWAM{XrOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIK1W4hKSzVyPUiuO|g6PCEQvF2=MXXTRW5ITVJ?
TE-9MlL0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUjJR|UxRThwOEGwOlIh|ryPM2iyenNCVkeHUh?=
NB13MnTtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUfJR|UxRThwOEO3PVYh|ryPNILmVm9USU6JRWK=
BPH-1M4i3TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUDXVXRrUUN3ME24Mlg2ODhzIN88US=>M1TUbHNCVkeHUh?=
KMOE-2NE[zTmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=Ml\NTWM2OD16Lki3PFkzKM7:TR?=MUHTRW5ITVJ?
RPMI-8402NY\2VZd4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUfWZ|RIUUN3ME24Mlg6QTJ4IN88US=>M2mwcXNCVkeHUh?=
OVCAR-3M{f3dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGW1fmZKSzVyPUiuPVc4OzJizszNMXrTRW5ITVJ?
NCI-H2196NXfxN|c{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mki5TWM2OD16Lkm4OlA3KM7:TR?=NWfHb441W0GQR1XS
MZ7-melM4q2PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTacGdxUUN3ME25MlA{PDZizszNMXzTRW5ITVJ?
GP5dMV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTlwME[zNVMh|ryPNHjCNYVUSU6JRWK=
NCI-N87NVz3T4hVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M33w[WlEPTB;OT60OFc{OSEQvF2=Mm\4V2FPT0WU
EW-16NFTqXVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVPoOmZiUUN3ME25MlQ1QDR6IN88US=>NH;hN4FUSU6JRWK=
Calu-6MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWXJR|UxRTlwNEm3NFMh|ryPNEn3Rm9USU6JRWK=
LC4-1MnXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH3OXJJKSzVyPUmuOlI2PyEQvF2=NYTDWVZ2W0GQR1XS
CCRF-CEMM37Hcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NYTzUJR[UUN3ME25MlY5PzZ4IN88US=>M{HBW3NCVkeHUh?=
BC-1MlvKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnLvTWM2OD17Lke4PVkh|ryPM1vx[XNCVkeHUh?=
NCI-SNU-16NX3pdnBCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1O1dWlEPTB;OT63PVQ6PSEQvF2=MWDTRW5ITVJ?
NCI-H28NX3wNWJPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEL4Z2xKSzVyPUmuPFQ6OzNizszNM1frbHNCVkeHUh?=
SBC-1M4Pt[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1;kXGlEPTB;MUCuNFczKM7:TR?=MVXTRW5ITVJ?
TURNIfNVpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M2mzcGlEPTB;MUCuNVY2PyEQvF2=NWLSeIxCW0GQR1XS
MDA-MB-231MnPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWracIRMUUN3ME2xNE4zOTF2IN88US=>Mkf4V2FPT0WU
C3AMnfqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NID1dZpKSzVyPUGwMlMyPzlizszNNFfwV|ZUSU6JRWK=
SW1990MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1zCfmlEPTB;MUCuN|I5KM7:TR?=MXXTRW5ITVJ?
NCI-H1993NYmxeHRYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmPrTWM2OD1zMD61Olk{KM7:TR?=MVnTRW5ITVJ?
SK-CO-1M{TnSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M372TmlEPTB;MUCuO|c4KM7:TR?=MX7TRW5ITVJ?
OAW-28M3y0Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mn7pTWM2OD1zMD65PFg5KM7:TR?=NV;LXHhDW0GQR1XS
HNNHL6NVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVz2[FFRUUN3ME2xNU4yOTNzIN88US=>MWPTRW5ITVJ?
NCI-H1304M13ScGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3n3RWlEPTB;MUGuNVU4PiEQvF2=M{L2XnNCVkeHUh?=
DaoyMlz3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NH[yW2ZKSzVyPUGxMlQ{OzZizszNMmDTV2FPT0WU
VA-ES-BJMnnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUPJR|UxRTFzLkexPVUh|ryPM1P5U3NCVkeHUh?=
MCF7M4\KT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2ezXmlEPTB;MUGuPFEzPiEQvF2=M2nWOnNCVkeHUh?=
VM-CUB-1M2fkZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHXLcldKSzVyPUGxMlkxQTFizszNNGnuNoxUSU6JRWK=
IPC-298MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MV7JR|UxRTFzLkmzPFMh|ryPMVvTRW5ITVJ?
NCI-H2126M17MPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXvMNpgxUUN3ME2xNk4xOjF6IN88US=>Mki3V2FPT0WU
OVCAR-8NUXRUVhWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Ml\jTWM2OD1zMj6xNVQyKM7:TR?=NE\BRVNUSU6JRWK=
SJRH30NE\W[pZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH73cnRKSzVyPUGyMlIzQTlizszNNYexPVdDW0GQR1XS
DMS-53MmLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHfE[ZpKSzVyPUGyMlI3PDlizszNNGTDPZlUSU6JRWK=
NCI-H322MM1S2UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MVLJR|UxRTF{LkOzOVch|ryPNHzDUGpUSU6JRWK=
RVH-421MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXrJR|UxRTF{LkS5NFQh|ryPMonkV2FPT0WU
RajiM1LrSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M{XqeGlEPTB;MUKuOlE1KM7:TR?=MoPTV2FPT0WU
MDA-MB-415M{K0WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHHRcG9KSzVyPUGyMlY1PDRizszNNEfnVHRUSU6JRWK=
EFE-184NWTmSWppT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MYHJR|UxRTF{LkexNFYh|ryPNEXVU4xUSU6JRWK=
BFTC-909Mn7WS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MUHJR|UxRTF{LkmyOFch|ryPNVTaWHdKW0GQR1XS
BHYMkXaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHrKb21KSzVyPUGzMlM{QSEQvF2=NF;a[|hUSU6JRWK=
YKG-1NIqxNpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFn6ZllKSzVyPUGzMlM4PDlizszNNFTlUVhUSU6JRWK=
EW-3NYfuRoFVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWLJR|UxRTF|LkexOlMh|ryPMWDTRW5ITVJ?
HCC1143MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3TVUGlEPTB;MUOuO|Q{PyEQvF2=MkXsV2FPT0WU
REHM{HOfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MUHJR|UxRTF|Lki5PFIh|ryPMXrTRW5ITVJ?
CESSNUDURWprT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXz0W5l5UUN3ME2xN{46PDh7IN88US=>M1HD[HNCVkeHUh?=
EFM-19NXTxVoZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV[4ZoNbUUN3ME2xOE4yOTF{IN88US=>M4nRRnNCVkeHUh?=
U031NGX6V3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MXHJR|UxRTF2LkSwPFUh|ryPMlPNV2FPT0WU
ES1MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1;RTWlEPTB;MUSuOFg2OSEQvF2=NYjnZVJjW0GQR1XS
HSC-3MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkjUTWM2OD1zND62NlE2KM7:TR?=MYXTRW5ITVJ?
LOXIMVIMmLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NIX6ZVJKSzVyPUG0MlcxPjhizszNNYe0eXJvW0GQR1XS
A388M1y1Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MorXTWM2OD1zND63OVU3KM7:TR?=MWrTRW5ITVJ?
KP-N-YSMWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M3qxSGlEPTB;MUSuO|c{KM7:TR?=NH;RXYpUSU6JRWK=
Capan-2M3XSTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4C0cmlEPTB;MUSuO|g3KM7:TR?=MYTTRW5ITVJ?
SKG-IIIaM4rONmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MkXiTWM2OD1zND64PFYzKM7:TR?=NYq1S2dXW0GQR1XS
HELMonFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkPuTWM2OD1zND64PVk4KM7:TR?=NV:2fJFHW0GQR1XS
BENMXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NH3wdWtKSzVyPUG0Mlk4PjZizszNMoHkV2FPT0WU
MC116NULwOXdRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NX3WcYJUUUN3ME2xOU4yPTl7IN88US=>MX3TRW5ITVJ?
IGROV-1NUPQcGRST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTF3LkKzNVch|ryPNVzBfXg6W0GQR1XS
NCI-H1648NWrOenVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1iwWmlEPTB;MUWuOVMxPSEQvF2=M2m1enNCVkeHUh?=
ABC-1MlvyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{mxbWlEPTB;MUWuPFA{OyEQvF2=MXPTRW5ITVJ?
EW-18NGHOVpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M13xcGlEPTB;MUWuPVk4QSEQvF2=Mm\2V2FPT0WU
BC-3NF:0bWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmDRTWM2OD1zNj6wOVYzKM7:TR?=M2\xT3NCVkeHUh?=
NCI-H1437MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MY\JR|UxRTF4LkC2Olch|ryPM3zWWHNCVkeHUh?=
SCC-15NWfPVHczT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NUnJcVVbUUN3ME2xOk4zQDJ3IN88US=>M4G2VnNCVkeHUh?=
TTMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NWiwO|Z1UUN3ME2xOk42QDh6IN88US=>NUnV[pAxW0GQR1XS
KINGS-1NVjjVVlET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1TPfGlEPTB;MU[uPFI4OyEQvF2=MVrTRW5ITVJ?
C32MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NG\nRoxKSzVyPUG2Mlk4OTdizszNMX3TRW5ITVJ?
SBC-5NV;mRmJIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlnoTWM2OD1zNz6xOFc6KM7:TR?=MUPTRW5ITVJ?
NB1M2D6eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NU\0dHczUUN3ME2xO{4{OTh6IN88US=>NV3URoc3W0GQR1XS
EB-3MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MljoTWM2OD1zNz61O|Yh|ryPNV;ZRYFpW0GQR1XS
NCI-H748MnvZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXzJR|UxRTF5LkewN|Uh|ryPM4\IfHNCVkeHUh?=
IST-SL1M2\yNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MojETWM2OD1zNz63OVI3KM7:TR?=NVHBb49NW0GQR1XS
WM-115M1nLZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGjwb2NKSzVyPUG3MlgxQDVizszNMkLOV2FPT0WU
NCI-H226M1i2Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGnlb3JKSzVyPUG3Mlk2PDZizszNNGK4Oo1USU6JRWK=
CAL-33NVLBW5ZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Moj0TWM2OD1zOD6yO|gyKM7:TR?=M4Py[3NCVkeHUh?=
SCC-4NYrOblVCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWnJR|UxRTF6LkOyNlkh|ryPMUTTRW5ITVJ?
RMG-IMVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkHPTWM2OD1zOD62PVQ4KM7:TR?=NHPOeGFUSU6JRWK=
KOSC-2MnH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M4LuNmlEPTB;MUiuO|c1PiEQvF2=NGXldY5USU6JRWK=
A2058MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4PZTWlEPTB;MUiuPFI2PSEQvF2=MU\TRW5ITVJ?
HCC70M1zGeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2LKWGlEPTB;MUmuN|g6PCEQvF2=NHzDbXRUSU6JRWK=
C2BBe1NXvQdGZKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NE\zdIxKSzVyPUG5MlQyPDhizszNMoXUV2FPT0WU
NCI-H650NILvc2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M17PVGlEPTB;MUmuOVg6QSEQvF2=NIjC[3hUSU6JRWK=
CAL-72MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4ftTmlEPTB;MUmuOlc{PyEQvF2=NWG3RmJOW0GQR1XS
L-363MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MVLJR|UxRTJyLkCyNVIh|ryPNV\CPIFoW0GQR1XS
SNU-423MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFvJPZdKSzVyPUKwMlExPDNizszNMkPmV2FPT0WU
PLC-PRF-5MmPXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXnJR|UxRTJyLkO5NFYh|ryPNXuwPZd1W0GQR1XS
SW1463NHfuXWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MkW0TWM2OD1{MD60OVI2KM7:TR?=NVrySmpQW0GQR1XS
769-PM{HvWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1T1WmlEPTB;MkCuOlc3QSEQvF2=NGLXZlhUSU6JRWK=
DMS-79Ml[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWrJR|UxRTJyLki0PUDPxE1?MWPTRW5ITVJ?
Saos-2M{\RdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NUjifoV5UUN3ME2yNE46PTV4IN88US=>NIfDVWlUSU6JRWK=
CHP-126NFTnRlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M3HxSGlEPTB;MkGuOFQ3OiEQvF2=M1P1UnNCVkeHUh?=
SW837MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2\0U2lEPTB;MkGuOFk{QSEQvF2=NE\jfHZUSU6JRWK=
SHP-77MkTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NHLXTlNKSzVyPUKxMlYyOjJizszNMVTTRW5ITVJ?
DBMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYXJR|UxRTJzLk[xOFIh|ryPM3Hj[XNCVkeHUh?=
ES5MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MnzKTWM2OD1{MT62PFY1KM7:TR?=MVPTRW5ITVJ?
COR-L23MnjvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NF7hTmpKSzVyPUKxMlgxPTFizszNMWXTRW5ITVJ?
KU-19-19M1rJemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MXvJR|UxRTJzLki5PFIh|ryPMUfTRW5ITVJ?
T84Ml:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVzJR|UxRTJzLkm4NVkh|ryPNFHuUYlUSU6JRWK=
NCI-H630NUf1UppXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NFPxbXVKSzVyPUKyMlU{PjNizszNNXLlR3J7W0GQR1XS
LU-165MnyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NFn1RW9KSzVyPUKyMlU2PCEQvF2=MnnQV2FPT0WU
COLO-792NX;pW2ZiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M{Pm[GlEPTB;MkKuO|EyOSEQvF2=MkixV2FPT0WU
CAL-62MnjXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUi1fnZYUUN3ME2yNk44PTF5IN88US=>MYHTRW5ITVJ?
HCE-TNInsNFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M1\iOGlEPTB;MkKuPFYxPiEQvF2=M3fES3NCVkeHUh?=
BB65-RCCM{DWS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4DMWmlEPTB;MkOuNFM1PCEQvF2=MYjTRW5ITVJ?
SiHaMVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2PLTWlEPTB;MkOuN|k3QCEQvF2=NUjUVWVHW0GQR1XS
NCI-H2081NXvhO|hiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=Mo\6TWM2OD1{ND6wOlQyKM7:TR?=MnznV2FPT0WU
U251NULaTZVKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NIrpbWdKSzVyPUK0MlA3PjhizszNNHr5Zm1USU6JRWK=
LoVoMmLHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NGT1SIRKSzVyPUK0MlkzQDJizszNMoLoV2FPT0WU
GCIYNUXQZXc6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MnTBTWM2OD1{NT6yPFc4KM7:TR?=NEGwNpJUSU6JRWK=
NUGC-3NWjiSW5YT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M3n4UGlEPTB;MkWuN|MyPiEQvF2=M3\sOnNCVkeHUh?=
LNCaP-Clone-FGCMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MWrJR|UxRTJ3LkO0PVgh|ryPNGjJUmtUSU6JRWK=
PA-1NVHyfYU1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVHJR|UxRTJ3Lk[4N|Mh|ryPNHXydG5USU6JRWK=
OE33MmTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXHJR|UxRTJ3Lk[4OVMh|ryPMn\yV2FPT0WU
HT-29M3LBUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mlz4TWM2OD1{NT63PFc6KM7:TR?=NEP6SYpUSU6JRWK=
RCM-1NF3Sd|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{PJO2lEPTB;MkWuPVY2PiEQvF2=Mne5V2FPT0WU
NCI-H1522NF\vNGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NULJR5lZUUN3ME2yOU46QTFzIN88US=>M3v3S3NCVkeHUh?=
LB373-MEL-DNGPtO|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGjxUGxKSzVyPUK2MlE4ODhizszNM4[y[XNCVkeHUh?=
NCI-H1436NVjGNYh{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MX7JR|UxRTJ4LkK3N|gh|ryPMULTRW5ITVJ?
COLO-824MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYjJR|UxRTJ4LkSwNFIh|ryPMXzTRW5ITVJ?
CP50-MEL-BM2rSRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NEPmVpdKSzVyPUK2MlU3PzVizszNMluwV2FPT0WU
EGI-1MkLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVLJR|UxRTJ5LkK2PVgh|ryPM3ywNHNCVkeHUh?=
LAN-6NVHo[ZZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M1i4WGlEPTB;MkeuN|U6QCEQvF2=MVfTRW5ITVJ?
GAKMlrkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NYr0cok5UUN3ME2yO{41OjJ3IN88US=>NYTvNoJ7W0GQR1XS
MDA-MB-175-VIIMXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MYTJR|UxRTJ5LkWwOVMh|ryPMk\mV2FPT0WU
JVM-2NGLENZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MYjJR|UxRTJ5Lk[2NlIh|ryPM3TU[XNCVkeHUh?=
UACC-257NEnjdlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlPDTWM2OD1{Nz62PFc5KM7:TR?=MW\TRW5ITVJ?
SW1783NEHjfYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MWDJR|UxRTJ5Lke3PFMh|ryPMWjTRW5ITVJ?
HT-3M3jWOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXv0ZoFNUUN3ME2yPE4zOTZ4IN88US=>M1fiV3NCVkeHUh?=
RLMm\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NUP0elhKUUN3ME2yPE42QTFzIN88US=>M4niRXNCVkeHUh?=
TK10MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MoKwTWM2OD1{OD62OVM2KM7:TR?=NIL6WYJUSU6JRWK=
HT55M2LzWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NGDaNJNKSzVyPUK5MlA2PjVizszNM1\SVHNCVkeHUh?=
BT-20M{\iXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NIXUc3NKSzVyPUK5MlA2QDZizszNMXnTRW5ITVJ?
TGBC24TKBNWrJfYpwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXjlXnhrUUN3ME2yPU4yQDNzIN88US=>NGrJfJRUSU6JRWK=
HSC-2MoLuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MkfSTWM2OD1{OT6zNFAyKM7:TR?=M2DyWHNCVkeHUh?=
COLO-205NGfRc2RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M4DSV2lEPTB;MkmuN|k1PCEQvF2=MVXTRW5ITVJ?
GT3TKBMVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NInUT5FKSzVyPUK5MlY5PzdizszNMYHTRW5ITVJ?
T47DMU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFHESXdKSzVyPUK5Mlg2QDJizszNMnjPV2FPT0WU
OMC-1MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUjJR|UxRTNyLkG5NVkh|ryPM3\aOXNCVkeHUh?=
PFSK-1M4LhbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M3;ZOmlEPTB;M{GuNlY2QSEQvF2=NVXhSZdoW0GQR1XS
JEG-3NED3[WtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVTV[VNtUUN3ME2zNU4{PTZzIN88US=>MXPTRW5ITVJ?
RDNV3J[GJ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYTGNopsUUN3ME2zNU42OTF3IN88US=>NW\lO4U1W0GQR1XS
NCI-H64NWH6RXNzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MWPJR|UxRTN{LkSxO|kh|ryPNH3JTVFUSU6JRWK=
DMS-114NGXRW3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHvVPJNKSzVyPUOyMlQyQDJizszNMnXVV2FPT0WU
NCI-H661M1ztRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NFfTSW1KSzVyPUOyMlY2ODFizszNNEfUd2tUSU6JRWK=
CAL-148NG\OfGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MmjPTWM2OD1|Mj62OlY2KM7:TR?=MlruV2FPT0WU
HuP-T3Ml;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NV;hcXg5UUN3ME2zNk46OzN6IN88US=>MofxV2FPT0WU
ES4NXXpfIFzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MVrJR|UxRTN|LkG3NFUh|ryPNVW3R2lTW0GQR1XS
Ca9-22NV75fXBCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHKyfmlKSzVyPUOzMlQ3ODFizszNMljzV2FPT0WU
LP-1NYfYT|YyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MlTUTWM2OD1|ND6wPUDPxE1?NEX1fXJUSU6JRWK=
AU565MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MXHJR|UxRTN2LkWwOlkh|ryPNGDBdo1USU6JRWK=
MDA-MB-453MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M{e4XWlEPTB;M{WuNVQzPiEQvF2=MV;TRW5ITVJ?
SNU-C1M{nGdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NXTlV4RtUUN3ME2zOU4yPzFizszNNHvtT2ZUSU6JRWK=
SW13NXztVGY5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MmSwTWM2OD1|NT60NFc3KM7:TR?=NFfnb5ZUSU6JRWK=
NCI-H2122M1fQXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7NHr3cllKSzVyPUO1MlU2QThizszNMWjTRW5ITVJ?
NCI-H1395MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NVPhe4hsUUN3ME2zOU43PjlzIN88US=>MVjTRW5ITVJ?
J-RT3-T3-5MoGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M33lbGlEPTB;M{[uNFI6PCEQvF2=MWHTRW5ITVJ?
COR-L279NWnifGRTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NHX6ZY1KSzVyPUO2MlE6QDFizszNMly5V2FPT0WU
ATN-1MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MmXFTWM2OD1|Nj64OVE3KM7:TR?=M1PEZnNCVkeHUh?=
HCC2998NYX5VZJTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MkLGTWM2OD1|Nj64OVcyKM7:TR?=NEPUfYNUSU6JRWK=
UM-UC-3Mnf3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MXjJR|UxRTN4Lki2O|Uh|ryPM1jCeHNCVkeHUh?=
DV-90M4Dudmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M2rPNGlEPTB;M{[uPVA3PyEQvF2=MWfTRW5ITVJ?
ES8MoL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlvtTWM2OD1|Nj65N|E5KM7:TR?=NVTG[o5rW0GQR1XS
YAPCNUjHToRDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M4TZZWlEPTB;M{[uPVY2PCEQvF2=MnO0V2FPT0WU
HCC1599MoTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M{HzfWlEPTB;M{euNVYyQCEQvF2=MlPYV2FPT0WU
UMC-11NHexOZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NFf1VY9KSzVyPUO3MlI2ODNizszNMlTaV2FPT0WU
THP-1MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M2qyXGlEPTB;M{euNlg3QCEQvF2=M1vyNnNCVkeHUh?=
OCUB-MM33qNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M1PjR2lEPTB;M{euNlg6OSEQvF2=NHvseG5USU6JRWK=
NCI-H1693MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MornTWM2OD1|Nz6zNlM{KM7:TR?=MYjTRW5ITVJ?
NCI-H345MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NXy3cXk3UUN3ME2zO{4{PjJ2IN88US=>Mn3mV2FPT0WU
COLO-800MmeyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MVjJR|UxRTN5LkW2O{DPxE1?NIPTOJBUSU6JRWK=
COLO-320-HSRMlLBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX;JR|UxRTN6LkO0PVIh|ryPNWLHc404W0GQR1XS
NCI-H596M2fYb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7MX7JR|UxRTN6LkS0PFkh|ryPM4\jWHNCVkeHUh?=
NCI-H187MnuyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?M1;kOmlEPTB;M{iuO|M1PCEQvF2=M1PtVnNCVkeHUh?=
ECC4NHTIWGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NVHNb|dTUUN3ME2zPU4xQDF2IN88US=>Mom3V2FPT0WU
KP-4NYCxWI45T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NWDSOWdxUUN3ME2zPU4yOjN3IN88US=>MmTVV2FPT0WU
NCI-H2227M3q0[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7M4mxZWlEPTB;M{muN|k1QSEQvF2=NGHrbWdUSU6JRWK=
22RV1M1v4TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7MnzNTWM2OD1|OT64N|k5KM7:TR?=M3nRVnNCVkeHUh?=
SASNXfqem1[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=M2\tUmlEPTB;NECuNFk3KM7:TR?=NXvWXWgzW0GQR1XS
PANC-10-05MniyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MWfJR|UxRTRyLkG4Nlgh|ryPMYnTRW5ITVJ?
MDA-MB-468MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M1fibmlEPTB;NECuOVM1PiEQvF2=NV;FSXhUW0GQR1XS
RPMI-7951MnLTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?Mo\5TWM2OD12MT6yNFc2KM7:TR?=NULWWWVHW0GQR1XS
BB49-HNCMYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?NFTYXZBKSzVyPUSxMlIyPzlizszNM1nycXNCVkeHUh?=
23132-87MorRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MX3JR|UxRTRzLkK3N|Ih|ryPMoX5V2FPT0WU
HCC1569NFT3[FBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NGXUSYZKSzVyPUSxMlI5QDVizszNMX3TRW5ITVJ?
CP66-MELNYPXZotXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NEX6dmpKSzVyPUSyMlE5QDZizszNM1XWd3NCVkeHUh?=
K-562MmnVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnHSTWM2OD12Mj6yPFU1KM7:TR?=NHeyU4VUSU6JRWK=
OCI-AML2NX74WFR3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MY\JR|UxRTR{Lki5O|Qh|ryPNXvtN4pIW0GQR1XS
SW756NV7IdZlRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NV[1WZBEUUN3ME20N{4xOzh6IN88US=>MoT4V2FPT0WU
M14MmTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MlzDTWM2OD12Mz6zNVg6KM7:TR?=MkfMV2FPT0WU
NCI-H1623NVz3e3Z3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYf3dmZQUUN3ME20N{41PjRizszNNVy2Nmw5W0GQR1XS
KNS-81-FDMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MkLzTWM2OD12Mz63OlIh|ryPMnvGV2FPT0WU
TGBC1TKBMonMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MljFTWM2OD12Mz65NFk6KM7:TR?=MV7TRW5ITVJ?
RERF-LC-MSMVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MW\JR|UxRTR|LkmyPFEh|ryPMXjTRW5ITVJ?
PC-3MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?MUnJR|UxRTR2LkSzOFch|ryPMnPTV2FPT0WU
HuP-T4Mn7xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NEPzUnpKSzVyPUS0MlQ1PzRizszNM2r5enNCVkeHUh?=
NCI-H510ANGDKNlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=M{nEPWlEPTB;NESuO|A5KM7:TR?=NIHqPWlUSU6JRWK=
LB2518-MELMnHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnPaTWM2OD12ND63PVM4KM7:TR?=NIOzboZUSU6JRWK=
TE-5NFuzVolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NWGx[WMzUUN3ME20OU46PThzIN88US=>MnKwV2FPT0WU
EW-24NWHTeXZuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NXPkbFN4UUN3ME20Ok4yPzJ|IN88US=>M4K3c3NCVkeHUh?=
LB647-SCLCNHPid3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NHfjWnpKSzVyPUS2MlIyPTVizszNNWjrfGdbW0GQR1XS
NCI-H524NG\6fYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NH3wNIVKSzVyPUS2MlcyQDVizszNNIPOXYdUSU6JRWK=
EW-11NVS3OGZoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYHxWmsyUUN3ME20Ok46Ozd|IN88US=>NVT2T5BNW0GQR1XS
KALS-1NHH6[VJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=MlWzTWM2OD12Nz6yNFY3KM7:TR?=M33OO3NCVkeHUh?=
BT-474NH7kNWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NYKzSZhWUUN3ME20O{41OjF4IN88US=>M3vqbXNCVkeHUh?=
SK-N-ASM3fsU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7Mk\zTWM2OD12Nz64PFgh|ryPNH3jN3BUSU6JRWK=
HCC2157NXWzZXMxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=NYfOSWZMUUN3ME20PE4xPzZizszNMmTnV2FPT0WU
HCC1954Ml3CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MnryTWM2OD12OD6xO|A1KM7:TR?=NWDLTJJIW0GQR1XS
FADUNUXlS|BiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm=MXnJR|UxRTR6LkOwN|Eh|ryPNX7FT3pnW0GQR1XS
S-117MnrjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?MYTJR|UxRTR6LkO4NVUh|ryPNY\ZU|ZiW0GQR1XS
LS-1034NFvzfmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NEjhSFJKSzVyPUS4MlcxPjdizszNNVe2XlNuW0GQR1XS
CAMA-1NHHiNXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=NUixXpNQUUN3ME20PU42PTR|IN88US=>NHXER2tUSU6JRWK=
LU-134-AMWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?M4TvNWlEPTB;NEmuPFA5PSEQvF2=NIXFbJVUSU6JRWK=
NCI-H1838MonzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?NWXqRo8yUUN3ME20PU45ODh5IN88US=>NYP3e41UW0GQR1XS

... Click to View More Cell Line Experimental Data

In vivo In a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, AP24534 (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors. [2]
Features

Protocol(Only for Reference)

Kinase Assay: [1]

Peptide substrate phosphorylation assays with GST-Abl kinase domains The effect of AP24534 (0-320 nM) on GST-Abl kinase activity is assessed by using a synthetic peptide substrate (Abltide: EAIYAAPFAKKK). Assays are carried out at 30 °C for 15 min in 25 μL reaction mixture: 8 mM MOPS (pH 7), 0.2 mM EDTA, 50 μM Abltide, 30 mM MgCl2, 10 mM β-glycerol phosphate, 1 mM EGTA, 0.002% Brij-35, 0.4 mM DTT, 0.2 mg/mL BSA, 0.4 mM sodium orthovanadate, 10 nM WT or mutant GST-Abl kinase, and 100 µM ATP/γ-32[P]ATP (5000 cpm/pmol). Reactions are terminated by transferring a portion of the reaction mixture onto a p81 phosphocellulose filter and immersing in 0.75% phosphoric acid. Filters are washed 3 times in 0.75% phosphoric acid, rinsed in acetone, and air dried; phosphate incorporation is determined by scintillation counting. All results are corrected for background binding to the filters, as determined by omitting peptide substrate from the kinase reaction. Time course experiments to establish the linear range of enzymatic activity precedes kinase assays.

Cell Assay: [2]

Cell lines Ba/F3 cells expressing Bcr-Abl or a range of single mutations in the kinase domain of Bcr-Abl
Concentrations 0-625 nM
Incubation Time 72 hours
Method Ba/F3 cell lines are distributed in 96-well plates (4 × 103 cells/well) and incubated with AP24534 for 72 hours. Proliferation is measured using a methanethiosulfonate (MTS)-based viability assay (CellTiter96 Aqueous One Solution). All values are normalized to the control wells with no drug. IC50 values are reported as the mean of three independent experiments performed in quadruplicat

Animal Study: [1]

Animal Models Mouse xenograft models of Ba/F3 cells expressing Bcr-Abl or Bcr-AblT315I
Formulation Dissolved in 25 mM citrate buffer, pH 2.75
Dosages 2.5 mg/kg and 5 mg/kg for Ba/F3 Bcr-Abl; 2.5 mg/kg–50 mg/kg for Ba/F3 Bcr-AblT315I
Administration Oral gavage once daily

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] O'Hare T, et al. Cancer Cell, 2009, 16(5), 401-412.

[2] Huang WS, et al. J Med Chem, 2010, 53(12), 4701-4719.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-23)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT02776605 Not yet recruiting ALL PETHEMA Foundation June 2016 Phase 2
NCT01888562 Withdrawn Endometrial Neoplasms Washington University School of Medicine January 2016 --
NCT02627677 Recruiting Chronic Phase Chronic Myeloid Leukemia Ariad Pharmaceuticals December 2015 Phase 3
NCT02398825 Not yet recruiting Chronic Myeloid Leukemia|Chronic Phase|Adults Gruppo Italiano Malattie EMatologiche dellAdulto December 2015 Phase 2
NCT02779283 Recruiting Untreated Adult Acute Myeloid Leukemia OHSU Knight Cancer Institute|National Cancer Institute (NCI) December 2015 Phase 1

view more

Chemical Information

Download Ponatinib (AP24534) SDF
Molecular Weight (MW) 532.56
Formula

C29H27F3N6O

CAS No. 943319-70-8
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 30 mg/mL (56.33 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo 30% PEG400+0.5% Tween80+5% propylene glycol 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 3-(2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Customer Product Validation(2)


Click to enlarge
Rating
Source Cancer Cell 2012 22(5), 656-667 . Ponatinib (AP24534) purchased from Selleck
Method Western blot
Cell Lines RCH-ACV cells
Concentrations 50 nM
Incubation Time 1-24 h
Results Treatment of these cells with a CSK inhibitor (BMS-599626) or a BTK inhibitor (PCI-32765) did not recapitulate the dasatinib/ponatinib phenotype.

Click to enlarge
Rating
Source Genome Biol, 2014, 15(8): 428 . Ponatinib (AP24534) purchased from Selleck
Method Cell Proliferation Assay
Cell Lines KatoIII cells
Concentrations 0-0.5 nM
Incubation Time
Results Each of the inhibitors demonstrated a statistically significant lower IC50 in FGFR2-amplified KatoIII cells compared to non-FGFR2-amplified AGS cells at all concentrations tested.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Bcr-Abl Products

  • PX-478 2HCl

    PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-1α) inhibitor. Phase 1.

  • Defactinib (VS-6063, PF-04554878)

    Defactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.

  • SU6656

    SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.

  • Imatinib Mesylate (STI571)

    Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM in cell-free or cell-based assays, respectively.

  • Nilotinib (AMN-107)

    Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine myeloid progenitor cells.

    Features:A selective inhibitor of native and mutant Bcr-Abl.

  • Bafetinib (INNO-406)

    Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl/Lyn inhibitor with IC50 of 5.8 nM/19 nM in cell-free assays, does not inhibit the phosphorylation of the T315I mutant and is less potent to PDGFR and c-Kit. Phase 2.

    Features:Dual Bcr-Abl/Lyn inhibitor.

  • Degrasyn (WP1130)

    Degrasyn (WP1130) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).

    Features:WP1130 has an advantage over imatinib mesylate in that its activity is not inhibited by a variety of Abl kinase mutations, including T315I.

  • DCC-2036 (Rebastinib)

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Features:A conformational control inhibitor of Abl1 and T315I Abl1.

  • GZD824 Dimesylate

    GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

  • GNF-2

    GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.

Recently Viewed Items

Tags: buy Ponatinib (AP24534) | Ponatinib (AP24534) ic50 | Ponatinib (AP24534) price | Ponatinib (AP24534) cost | Ponatinib (AP24534) solubility dmso | Ponatinib (AP24534) purchase | Ponatinib (AP24534) manufacturer | Ponatinib (AP24534) research buy | Ponatinib (AP24534) order | Ponatinib (AP24534) mouse | Ponatinib (AP24534) chemical structure | Ponatinib (AP24534) mw | Ponatinib (AP24534) molecular weight | Ponatinib (AP24534) datasheet | Ponatinib (AP24534) supplier | Ponatinib (AP24534) in vitro | Ponatinib (AP24534) cell line | Ponatinib (AP24534) concentration | Ponatinib (AP24534) nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us